Peptidomimetics and their applications in antifungal drug design

Anti-Infective Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2009, Pages 327-344

  Moradi, Shoeib ^a   Soltani, Saeed ^a   Ansari, Alireza M ^a   Sardari, Soroush ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA BASRUBRIN; BREVIN 2; CECROPIN B; CICADIN; CICERARIN; CILOFUNGIN; COCCININ; DROSOMYCIN; ESCULENTIN 1; GOSERELIN; GYMNIN; HALOCIDIN; HELIOFERIN A; HEMOPOIETIC GROWTH FACTOR; HISTATIN 3; ITURIN A; LEUCINOSTATIN A; MAGAININ 2; MELITIN; NIKKOMYCIN X; PEPTIDOMIMETIC AGENT; PININ; POLYOXIN D; PROTEGRIN 1; SCHIZOTRIN A; TENECIN; TRIPTORELIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZEAMATIN;

ANTIFUNGAL ACTIVITY; ARTICLE; ARTIFICIAL NEURAL NETWORK; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDA KRUSEI; COCCIDIOIDES IMMITIS; COMPUTER AIDED DESIGN; CRYPTOCOCCUS NEOFORMANS; DRUG CONFORMATION; DRUG DESIGN; ENDOCRINE TUMOR; FUNGICIDAL ACTIVITY; FUSARIUM OXYSPORUM; HUMAN; LIPID MEMBRANE; MOLECULAR DYNAMICS; MUCOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SACCHAROMYCES CEREVISIAE;

EID: 73549093186     PISSN: 18715214     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152109789760216     Document Type: Article

References (189)

1. Rahalison, L.; Hamburger, M.; Monod, M.; Frenk, E.; Hostettman, K. A bioautographic agar overlay method for the detection of antifungal compounds from higher plants. Phytochem. Anal., 1991, 2, 199-203.
2. Caceres, A.; Lopez, B.R.; Giron, M.A.; Logemann, H. Plants used in Guatemala for the treatment of dermatomucosal infections. 1: Screening of 38 plant extracts for anticandidal activity. J. Ethnopharmacol., 1991, 31, 263-276.
3. Kovacs, J.A.; Kovacs, A.A.; Polis, M.; Wright, W.C.; Gill, V.J.; Tuazon, C.U.; Gelmann, E.P.; Lane, H.C.; Longfield, R.; Overturf, G.; Macher, A.M.; Fauci, A.S.; Parillo, J.E.; Bennett, J.E.; Masur, H. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Int. Med., 1985, 103, 533-538.
4. Sardari, S.; Dezfulian, M. Evaluation of SAR for Amphotericin B Derivatives by Artificial Neural Network. Trop. J. Pharm. Res., 2005, 4, 517-521.
5. Alcouloumre, M.S.; Ghannoum, M.A.; Ibrahim, A.S.; Selsted, M.E.; Edwards, J.E. Fungicidal properties of defensin NP-1 and activity against Cryptococcus neoformans in vitro. Antimicrob. Agents Chemother., 1993, 37, 2628-2632.
6. Bulet, P.; Stocklin, R.; Menin, L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev., 2004, 198, 169-184.
7. Steiner, H.; Hultmark, D.; Engstrom, A.; Bennich, H.; Boman, H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature, 1981, 292, 246-248.
8. Ganz, T.; Selsted, M.E.; Szklarek, D.; Harwig, S.S.; Daher, K.; Bainton, D.F.; Lehrer, R.I. Defensins. Natural peptide antibiotics of human neuitrophils. J. Clin. Invest., 1985, 76, 1427-1435.
9. Devine, D.A.; Hancock, R.E.W. Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Des., 2002, 8, 703-714.
10. Kamysz, W.; Okruj, M.; Lukasiak, J. Novel properties of antimicrobial peptides. Acta. Biochim., 2003, 50, 461-469.
11. Baker, B., Zambryski, P.; Staskawicz, B.; Dinesh-Kumar, S.P. Signaling in plant-microbe interactions. Science, 1997, 276, 726-33.
12. Osusky, M.; Zhou, G; Osuska, L.; Hancock, R.E.; Kay, W.W.; Misra, S. Transgenic plants expressing cationic peptide chimeras exhibit broad-spectrum resistance to phytopathogens. Nat. Biotechnol., 2000, 18, 1162-1166.
13. Loffet, A. Peptides as drugs: is there a market?. J. Pept. Sci., 2002, 8, 1-7.
14. Travis, S.M.; Anderson, N.N.; Forsyth, W.R. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun., 2000, 68, 2748-55.
15. Hirata, M.; Shimomura, Y.; Yoshida, M. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect. Immun., 1994, 62, 1421-6.
16. Zanetti, M.; Gennaro, R.; Romeo, D. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett., 1995, 374, 1-5.
17. Sawa, T.; Kurahashi. K.; Ohara, M. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob. Agents Chemother., 1998, 42, 3269-75.
18. Hancock, R.E.W.; Chapple, D.S. Peptide antibiotics. Antimicrob. Agents Chemother., 1999, 43, 1317-1323.
19. Yeaman, R.M.; Yount Y.N. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 2003, 55, 27-55.
20. Shai, Y.; Oren, Z. From "carpet" mechanism to de novo designed diastereomeric cell-selective antimicrobial peptides. Peptides, 2001, 22, 1629 -1641.
21. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 2003, 55, 27-55.
22. Conlon, J.M.; Kolodziejek, J.; Nowotny, N. Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta., 2004, 1696, 1-14.
23. Yang, D.; Chertov, O.; Bykovskaia, S. N.; Chen, Q.; Buffo, M. J.; Shogan, J.; Anderson, M.; Schroder, J. M.; Wang, J. M.; Howard, O. M. Z.; Oppenheim, J. J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science., 1999, 286, 525-528.
24. Wade, D.; Boman, A.; Wåhlin, B.; Drain, C. M.; Andreu, D.; Boman, H. G.; Merrifield, R. B. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. U.S.A., 1990, 87, 4761-4765.
25. Matsuzaki, K.; Sugishita, K.; Harada, M.; Fujii, N.; Miyajima, K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta, 1997, 1327, 119-130.
26. Gennis, R. B. Molecular Structure and Function. Biomembrane, 1989, 1, 51-158.
27. Steiner, H.; Andreu, D.; Merrifield, R. B. Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim. Biophys. Acta, 1988, 939, 260-266.
28. Giangasparo, A.; Sandri, L.; Tossi, A. Amphipathic α-helical antimicrobial peptides, a systematic study of the effects of structural and physical properties on biological activity. Eur. J. Biochem., 2001, 268, 5589-5600.
29. Eunoh, J.; Hong S.U.; Lee, K.H. The comparison of characteristic between membrane-active antifungal peptide and its pseudo peptides. Bioorg. Med. Chem., 1999, 7, 2509-2515.
30. Shai, Y. Mode of action of membrane active antimicrobial peptides. Biopolymers, 2002, 66, 236-248.
31. Yang, L.; Harroun, T.A.; Weiss, T.M. L.; Ding, H.W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J., 2001, 81, 1475-1485.
32. Ehrenstein, G.; Lecar, H. Q. Electrically gated ionic channels in lipid bilayers. Rev. Biophys., 1977, 10, 1-34.
33. Banzet, N.; Lotris, M.P.; Bulet, P.; Francosis, E.; Deropierre, C.; Dubald, M. Expression of insect cystein-rich antifungal peptides in transgenic tobacco enhances resistance to a fungal disease. Plant Sci., 2002, 162, 995-1006.
34. Jang, W.S.; Kim H.K.; Lee K.Y.; Kim S.A.; Han Y.S.; Lee, I.H. Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium. FEBS Lett., 2006, 580, 1490-1496.
35. Kokryakov, V.N.; Harwig, S.S.; Panyutich, E.A.; Shevchenko, A.A.; Aleshina, G.M.; Shamova, O.; Korneva, H.A.; Lehrer, R.I. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett., 1993, 327(2), 23,1-6.
36. Wang, H.X.; Ng, T.B. Concurrent isolation of a Kunitz-type trypsin inhibitor with antifungal activity and a novel lectin from Pseudostellaria heterophylla roots. Biochem. Biophys. Res. Commun., 2006, 342, 349-353.
37. Kumar, M.; Chaturvedi, A.K.; Kavishavar, A.; Shukla, P.K.; Kesarwani, A.P.; Kundu, B. Identification of a novel antifungal nonapeptide generated by combinatorial approach. Int. J. Antimicrob. Agent., 2005, 25, 313-320.
38. Selsted, M.E.; Brown, D.M.; DeLange, R.J.; Harwig, S.S.; Lehrer, R.I. Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J. Biol. Chem., 1985, 260(8), 4579-84.
39. Skerlavaj, B.; Benincasa, M.; Risso, A.; Zanetti, M.; Renato, G. SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett., 1999, 463, 58-62.
40. Klotz, S.A.; Gaur, N.K.; Rauceo, J.; Lake, D.F.; Park, Y.; Hahm, S. Inhibition of Adherence and Killing of Candida albicans with a 23-Mer Peptide (Fn/23) with Dual Antifungal Properties. Antimicrob. Agent Chemother., 2004, 48 (11), 4337-4341.
41. Andra, J.; Berninghausen, O.; LEIPPE, M. Cecropins, antibacterial peptides from insects and mammals, are potently fungicidal against Candida albicans. Med. Microbiol. Immunol., 2001, 189, 169-173.
42. Gao, G.H.; Liu, W.; Dai, J.X.; Wang, J.F.; Hu, Z.; Zhang, Y.; Wang, D.C. Molecular scaffold of a new pokeweed antifungal peptide deduced by 1H nuclear magnetic resonance. Int. J. Bio. Macromol., 2001, 29, 251-258..
43. Cruciani, R.A.; Barker, J.L.; Durell, S.R.; Raghunathan, G.; Guy, H.R.; Zasloff, M.; Stanley, E.F. Magainin 2, a natural antibiotic from frog skin, forms ion channels in lipid bilayer membranes. Eur. J. Pharmacol., 1992, 226(4), 287-96
44. Michut, L.; Fehlbaum, P.; Moniatte, M.; Dorsselaer, A.V.; Reichhart, J.M.; Bulet, P. Determination of the disulfide array of the first inducible antifungal peptide from insects: drosomycin from Drosophila melanogaster. FEBS Lett., 1996, 395, 6 -10.
45. Kim, D. H.; Lee, Y.T.; Lee, Y. J.; Chung, J. H.; Lee, B. L.; Choi, B.S.; Lee, Y. Bacterial expression of tenecin 3, an insect antifungal protein isolated from Tenebrio molitor, and its efficient purification. Mol. Cell., 1998, 8(6), 786-9
46. Huang, R.H.; Xiang, Y.; Liu, X.Z.; Zhang, Y.; Hu, Z.; Wang, D. C. Two novel antifungal peptides distinct with a five-disulfide motif from the bark of Eucommiaulmoides Oliv. FEBS Lett., 2002, 521, 87-90.
47. Wang, H.; Ng, T.B. Isolation of cicadin, a novel and potent antifungal peptide from Juvenile cicadas. Peptides, 2002, 23, 7 -11.
48. Conlon, L.M.; Kolodziejek, J.; Nowontny, N. Antimicrobial peptides from rained frogs: Taxonomic and phylogenic markers and a potential source of new therapeutic agents. Biochim. Biophys. Acta, 2004, 1696, 1-14.
49. Ng, T.B. Antifungal proteins and peptides of leguminous and nonleguminous origin. Peptides, 2000, 25, 1215-1222.
50. Lee, D.G.; Shin, S.Y.; Maeng, C.Y.; Jin, Z.Z.; Kim, K.L.; Hahm, K.S. Isolation and characterization of a novel antifungal peptide from Aspergillus niger. Biochem. Biophys. Res. Commun., 1999, 263, 646 -651.
51. Lebbadi, M.; Gálvez, A.; Maqueda, M.; Martínez-Bueno, M.; Valdivia, E. Fungicin M4: a narrow spectrum peptide antibiotic from Bacillus licheniformis M-4. J. Appl. Bacteriol., 1994, 77(1), 49-53.
52. Jung, H. J.; Park, Y.; Hahm, K. S.; Lee, D.G. Biological activity of Tat (47-58) peptide on human pathogenic fungi. Biochem. Biophys. Res. Commun., 2006, 345, 222 -228.
53. Gräfe, U.; Ihn, W.; Ritzau, M.; Schade, W.; Stengel, C.; Schlegel, B.; Fleck, W. F.; Künkel, W.; Härtl, A.; Gutsche, W. Helioferins, novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structure, and biological properties. J. Antibiot., 1995, 48(2), 128-133.
54. Klich, A.; Arthur, K. S.; Lax, A.R.; Bland, J. M. Iturin A: a potential new fungicide for stored grains. Mycopathology, 1994, 127 (2), 453-460.
55. Fresta, M.; Ricci, M.; Rossi, C.; Furneri, P.M.; Puglisi, G. Antimicrobial Nonapeptide Leucinostatin A-Dependent Effects on the Physical Properties of Phospholipid Model Membranes. J. Coll. Inter. Sci., 2000, 226 (2), 222-230.
56. Krainer, E.; Naider, F.; Becker, J. M. Conformational studies of nikkomycin X in aqueous solution. Biopolymers, 1990, 29 (8), 1297 -1306.
57. Endo, A.; Kakiki, K.; Misato, T. Mechanism of Action of the Antifugal Agent Polyoxin D. J Bacteriol., 1970, 104(1), 189-196.
58. De Lucca, A. J.; Walsh, T. J. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother., 1999, 43(1), 1-11.
59. Fuji, E.; Fujita, Y.; Takaishi, T.; Fujita, I.; Arita, M.; Hiratsuka, N. New antibiotics, trichopolyns A and B: isolation and biological activity. Cel. Mol. Life Sci., 1978, 34(2), 253-361.
60. Adefarati, A.A.; Hensens, O.D.; Jones, E.T.; Tkacz, J.S. Pneumocandins from Zalerion arboricola. V. Glutamic acid- and leucine-derived amino acids in pneumocandin A0 (L-671,329) and distinct origins of the substituted proline residues in pneumocandins A0 and B0. J. Antibiot., 1992, 45(12), 1953-7.
61. Iwamoto, T.; Fujie, A.; Tsurumi, Y.; Nitta, K.; Hashimoto, S.; Okuhara, M. WF11899A, B and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties. J. Antibiot., 1990, 43(9), 1183-5.
62. Shigeru, O.; Mitsuo, H.; Sonoe, Y. Purification and properties of a new chitin-binding antifungal CB-1 from Bacillus licheniformis. Biosci. Biotechnol. Biochem., 1996, 60 (3), 481-483.
63. Wilson, S.; Mahiou, B.; Reiger, R.; Tentler, S.; Schimmoler, R.; Orndorff, S.; Selitrennikoff, C. P. Pilot-scale purification of zeamatin, an antifungal protein from maize. Biotechnol. Prog., 2000, 16(1), 38-43.
64. Tassin, S.; Broekaert, W. F.; Marion, D.; Acland, D. P.; Ptak, M.; Vovelle, F.; Sodano, P. Solution structure of Ace-AMP1, a potent antimicrobial protein extracted from onion seeds. Structural analogies with plant nonspecific lipid transfer proteins. Biochemistry, 1998, 37(11), 3623-37.
65. Wang, H.X.; Ng, T.B. An antifungal peptide from red lentil seeds. Peptides, 2007, 28 (3), 547-552.
66. Ngai, P.H.K..; Ng, TB. Coccinin, an antifungal peptide with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from large scarlet runner beans. Peptides, 2004, 25, 2063-2068.
67. Chu, K.T.; Liu, K.H.; Ng, T.B. Cicerann, a novel antifungal peptide from the green chickpea. Pep., 2003, 24, 659-663.
68. Wong, J.H.; Ng, T.B. Gymnin, a potent defensin-like antifungal peptide from the Yunnan bean (Gymnocladus chinensis Baill). Peptides, 2003, 24, 963-968.
69. Tanaka, H.; Satio, K.; Satio, Y.; Yamashita, T.; Agoh, M.; Okkunishi, J. Insect diapuse-specific peptide from the leaf beetle has consensus with a putative iridovirus peptide. Peptides, 2003, 24, 1327-1333.
70. Green, L.J.; Marder, P.; Mann, L. L.; Chio, L.; Current, W. L. LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability. Antimicrob. Agents Chemother., 1999, 43 (4), 830-835.
71. De Lucca, A.J.; Bland, J.M.; Grimm, C.; Jacks, T.J.; Cary, J.W.; Jaynes, J.M.; Cleveland,T.E.; Walsh.; T.J. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. J. Microbiol., 1998, 44, 514.520.
72. Oh, J.E.; Hong, S.U.; Lee, K.H. The comparison of characteristics between membrane-active antifungal peptide and its pseudopeptides. Bioorg. Med. Chem., 1999, 7, 2509-2515.
73. Faber, C.; Stallmann, H. P.; Lyaruu, D. M.; Blieck, J. M. A.; Bervoets, J. M.; Wuisman, P. I. J. M. Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads. J. Antimicrob. Chemother., 2003, 51, 1359-1364
74. Drouhet, E.; Dupont, B.; Improvisi, L.; Lesourd, M.; Prevost, M. C. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy. J. Med. Vet. Mycol., 1990, 28(6), 425-36.
75. Lee, M.T.; Chen, F.Y.; Huang, H.W. Energetics of pore formation induced by membrane active peptides. Biochemistry, 2004, 433, 590-3599.
76. Kim, C.; Spano, J.; Park, E.K.; Wi, S. Evidence of pores and thinned lipid bilayers induced in oriented lipid membranes interacting with the antimicrobial peptides, magainin-2 and aurein-3. BBABiomembr., 2009, 1788 (7), 1482-1496.
77. Patch, J.A.; Barron, A.E. Mimicry of bioactive peptides via nonnatural, sequence-specific peptidomimetic oligomers. Cur. Opin. Chem. Biol., 2002, 6, 872-877
78. Gellman, S.H. Foldamers: A Manifesto. Acc. Chem. Res., 1998, 31, 173-180
79. Guichard, G. In Pseudopeptides in Drug Development; P.E. Nielsen, Ed. Weinheim, Germany: Wiley-VCH Verlag, 2004; pp. 33-120.
80. Raguse, T.L.; Porter, E.A.; Weisblum, B.; Gellman, S.H. Structureactivity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J. Am. Chem. Soc., 2002, 124, 12774-12785.
81. Yoo, B.; Kirshenbaum, K. Peptoid architectures: elaboration, actuation, and application. Curr. Opin. Chem. Biol., 2008, 12 (6), 714-721.
82. Li, L., Thomas, R.M.; Suzuki, H.; De Brabander, J.K.; Wang, X.; Harran, P.G. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science, 2004, 3, 305, 1471-74.
83. Hruby, V. J.; Balse, P. M. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Curr. Med. Chem., 2000, 7, 945-970.
84. Hruby, V. J.; Li, G.; Haskell-Luevano, C.; Shenderovich, M. Design of peptides, proteins, and peptidomimetics in chi space. Biopolymers, 1997, 43, 219-266.
85. Ripka, A.S.; Rich, D.H. Peptidomimetic design. Cur. Opin. Chem. Biol., 1998, 2, 441-452.
86. Eguchi, M.; Shen, R. Y. W.; Shea, J. P.; Lee, M.S.; Kahn, M. Design, synthesis, and evaluation of opioid analogues with nonpeptidic beta-turn scaffold: enkephalin and endomorphin mimetics. J. Med. Chem., 2002, 45, 1395-1398.
87. Wang, W.; Yang, J.; Ying, J.; Xiong, C.; Zhang, J.; Cai, C.; Hruby, V. J. Stereoselective synthesis of dipeptide beta-turn mimetics: 7-benzyl and 8-phenyl substituted azabicyclo[4.3.0]nonane amino acid esters. J. Org. Chem., 2002, 67, 6353-6360.
88. Jean, F.; Buisine, E.; Melnyk, O.; Drobecq, H.; Odaert, B.; Hugues, M.; Lippens, G.; Tartar, A. Synthesis and structural and functional evaluation of a protein modified with a beta-turn mimic. J. Am. Chem. Soc., 1998, 120, 6076-6083.
89. Kaul, R.; Deechongkit, S.; Kelly, J. W. Synthesis of a negatively charged dibenzofuran-based beta-turn mimetic and its incorporation into the WW miniprotein-enhanced solubility without a loss of thermodynamic stability. J. Am. Chem. Soc., 2002, 124, 11900-11907.
90. Han, Y.; Giragossian, C.; Mierke, D. F.; Chorev, M. Ni-to-Ni+3-ethylene- bridged partially modified retro-inverso tetrapeptide betaturn mimetic: design, synthesis, and structural characterization. J. Org. Chem., 2002, 67, 5085-5097.
91. Szelke, M.; Leckie, B.; Hallett, A; Jones, D.M.; Sueiras, J.; Atrash, B. Potent new inhibitors of human renin. Nature, 1982, 299, 555-557.
92. Wiley, R.A.; Rich, D.H. Peptidomimetics derived from natural products. Med. Res. Rev. 1993, 13, 327-384.
93. Maibaum, V.; Cohen, N.C.; Rijeger, H.; Gschke, .R; Maibaum, J.; Cumin, F.; Fuhrer, W.; Wood, J.M. Bioactive hydroxyethylene dipeptide isosteres with hydrophobic (P3-P1)-moieties. A novel strategy towards small non-peptide renin inhibitors. Bioorg. Med. Chem. Lett., 1996, 6, 1589-l 594.
94. Goschke, R.; Cohen, N.C.; Wood, J.M.; Maibaum, J. Design and synthesis of novel 2,7-dialkyl substituted 5(S)-amino-4(S)-hydroxy-8-phenyl- octanecarboxamides as in vitro potent peptidomimetic inhibitors of human rennin. Bioorg. Med. Chem. Lett., 1997, 7, 2735-2740.
95. Dolle, R.E.; Prasad, C.V.C.; Prouty, C.P.; Salvino, J.M.; Awad, M.M.A.; Schmidt, S.J.; Hoyer, D.; Ross, T.M.; Graybill, T.L.; Speier, G.J. Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitor. J. Med. Chem., 1997, 40, 1941-l 946.
96. McKittrick, B.A.; Stamford, A.W.; Weng, X.; Ma, K.; Chackalamannil, S.; Czarniecki, M.; Cleven, R.M.; Fawzi, A.B. Design and synthesis of phosphinic acids that triply inhibit endothelin converting enzyme, angiotensin converting enzyme and neutral endopeptidase 24.11. Bioorg. Med. Chem. Lett., 1996, 6, 1629-l 634.
97. Brown, D.L.; Devadas, B.; Lu, H.F.; Nagarajan, S.; Zupec, M.E.; Freeman, S.K.; McWherter, C.A.; Getman, D.P.; Sikorski, J.A. Replacements for lysine in L-seryl-L-lysyl dipeptide amide inhibitors of candida albicans myristoyl-CoA:protein N-myristoyltransferase. Bioorg. Med. Chem. Lett., 1997, 7, 379-382.
98. Saute, M.; Rudolf, K.; Wittneben, H.; Herzog, H.; Martinez, R.; Munoz, M.; Eberlein, W.; Engel, W.; Walker, P.; Beck-Sickinger, A.G. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Pharmacology, 1996, 50, 285-292.
99. Brickmann, K.; Yuan, Z.; Sethson, I.; Somfai, P.; Kihlberg, J. Synthesis of conformationally restricted mimetics of gamma-turns and incorporation into desmopressin, an analogue of the peptide hormone vasopressin. Chem. Eur. J., 1999, 5, 2241-2253.
100. Yuan, Z.; Blomberg, D.; Sethson, I.; Brickmann, K.; Ekholm, K.; Johansson, B.; Nilsson, A.; Kihlberg, J. Synthesis and pharmacological evaluation of an analogue of the peptide hormone oxytocin that contains a mimetic of an inverse gamma-turn. J. Med. Chem., 2002, 45, 2512-2519.
101. Yuan, Z.; Kihlberg, J. Synthesis of a β-turn mimetic suitable for incorporation in the peptide hormone LHRH. Tetrahedron, 2005, 61, 4901-4909.
102. Lindman, S.; Lindeberg, G.; Nyberg, F.; Karlén, A.; Hallberg, A. Comparison of three γ-turn mimetic scaffolds incorporated into angiotensin II. Bioorg. Med. Chem., 2000, 8, 2375-2383.
103. Fairlie, D.P.; Abbenante, G.; March, D.R. Macrocyclic peptidomimetics-forcing peptides into bioactive conformations. Curr. Med. Chem., 1995, 2, 654-686.
104. Hanessian, S.; McNaughton-Smith, G.; Lombart, H.G.; Lubell, W.D. Design and Synthesis of Conformationally Constrained Amino Acids as Versatile Scaffolds and Peptide Mimetics. Tetrahedron, 1997, 53, 12789-l 2854.
105. Liverton, N.J.; Armstrong, D.J; Claremon, D.A; Remy, D.C.; Baldwin, J.J.; Lynch, R.J.; Zhang, G.; Gould, R.J. Nonpeptide glycoprotein IIb/IIIa inhibitors: substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists. Bioorg. Med. Chem. Lett., 1998, 8, 483-486.
106. Jones, M.R; Boatman, P.D; Semple, G.; Shin, Y.; Tamura, Y.S. Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors. J. Curr. Opin. Pharmacol., 2003, 3, 530-543.
107. Kruijtzer, J.A.W.; Lefeber, D.J.; Liskamp, R.M.J. Approaches to the Synthesis of Ureapeptoid. Peptidomimetics. Tetrahedron Lett., 1997, 38 (30), 5335-5338,
108. Terrett, N.K. Combinatorial Chemistry Online. J. Comb. Chem., 2008, 10 (8), 31-34.
109. Burgess, K.; Ibarzo, J.; Linthicum, D. S.; Russell, D. H.; Shin, H.; Shitangkoon, A.; Totani, R.; Zhang, A. J. Solid Phase Syntheses of Oligoureas. J. Am. Chem. Soc, 1997, 119, 1556- 1564
110. Han, H.; Janda, K. D. Azatides: Solution and Liquid Phase Syntheses of a New Peptidomimetic. J. Am. Chem. Soc, 1996, 118, 2539-2544.
111. Arvidsson, P.I.; Frackenpohl, J.; Ryder, N.S.; Liechty, B.; Petersen, F.; Zimmermann, H.; Camenisch, G.P.; Woessner, R.; Seebach, D. On the Antimicrobial and Hemolytic Activities of Amphiphilic beta-peptides. ChemBiochem., 2001, 2, 771-773.
112. Smith, A. B.; Benowitz, A. B.; Favor, D. A.; Sprengeler, P. A.; Hirschmann, R. A second-generation synthesis of scalemic 3,5,5-trisubstituted pyrrolin-4-ones: Incorporation of functionalized amino acid side-chains. Tetrahedron Lett., 1997,38, 3809-3812.
113. Bont, D. B. A.; Moree, W. J.; Liskamp, R. M. Molecular diversity of peptidomimetics: Approaches to the solid-phase synthesis of peptidosulfonamides . J. Bioorg. Med. Chem., 1996, 4, 667-672.
114. Wang, X.; Huq, I.; Rana, T. M. HIV-1 TAR RNA Recognition by an Unnatural Biopolymer. J. Am. Chem. Soc., 1997, 119, 6444-6445.
115. Hall, D. G.; Schultz, P. G. Synthesis of Diverse Ethoxyformacetal Oligomers. Toward Libraries of Metal-Coordinating Unnatural Biopolymers. Tetrahedron Lett., 1997, 38, 7825-7529.
116. Violette, A.; Fournel, S.; Lamour, L.; Chaloin, O.; Frisch, B.; Briand, J.; Monteil, H.; Guichard, G. Mimicking helical antibacterial peptides with nonpeptidic folding oligomers. J. Chem. Biol., 2006, 13, 531-538.
117. Stephens, O.M.; Kim, S.; Welch, B.D.; Hodsdon, M.E.; Kay, M.S.; Schepartz, A. Inhibiting HIV fusion with a β-peptide foldamer. J. Am. Chem. Soc., 2005, 127, 13126-13127.
118. Kritzer, J.A.; Stephens, O.M.; Guarracino, D.A.; Reznik, S.K.; Schepartz, A. beta-peptides as inhibitors of protein-protein interactions. Bioorg. Med. Chem., 2005, 13, 11-16.
119. Kritzer, J.A.; Lear, J.D.; Hodsdon, M.E.; Schepartz, A. Helical ßpeptide inhibitors of the p53-hDM2 interaction. Chem. Soc., 2004, 126, 9468-9469.
120. Klein, S.I.; Czekaj, M.; Gardner, C.J.; Guertin, K.R.; Cheney, D.L.; Spada, A.P.; Bolton, S.A.; Brown, K.; Colussi, D.; Heran, C.L. Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor Xa. J. Med. Chem., 1998, 41, 437-450.
121. Sall, D.J.; Bastian, J.A.; Briggs, S.L.; Buben, J.A.; Chirgadze, N.Y.; Clawson, D.K.; Denney, M.L.; Gierra, D.D.; Gifford-Moore, D.S.; Harper, R.W. Book of Abstracts. 214th American Chemical Society National Meeting: 1997 Sept 7-11: Las Vegas. Washington, DC: American Chemical Society; 1997:A58.
122. Chirgadze, N.Y.; Sal, D.J.; Klimkowski, V.J.; Clawson, D,K.; Briggs, S.L.; Hermann, R.; Smith, G.F.; Gifford-Moore, D.S.; Werv, J.P. The crystal structure of human alpha-thrombin complexed with LY178550, a nonpeptidyl, active site-directed inhibitor. Protein Sci., 1997, 6, 1412-l 417.
123. Hunt ,J.T.; Lee, V.G.; Leftheris, K.; Seizinaer, B.; Carboni, J.; Mabus, J.; Ricca, A.; Yan, N.; Manne V. Potent cell active not-thiol tetrapeptide inhibitors of Farnesyl transferase. J. Med. Chem., 1996, 39, 353-358.
124. Nioroae, F.G.; Doll, R.J.; Vibulbhan, B.; Alvarez, C.S.; Bishoo, W.R.; Pktrin, J.; Kirschmeier, P.; Carruthers, N.I.; Wong, J. Discovery of Novel Nonpeptide Tricyclic Inhibitors of Ras Farnesyl Protein Transferase. Bioorg. Med. Chem., 1997, 5, 101-l 13.
125. Bishop, W.R.; Bond, R.; Petrin, J.; Wang, L.; Patton, R.; Doll, R.; Njoroge, G.; Catino, J.; Schwartz, J.; Windsor, W. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells. J. Biol. Chem., 1995, 270, 3061 l-30618.
126. Lin, P.; Ganesan, A. Solid-phase synthesis of peptidomimetic oligomers with a phosphodiester backbone. Bioorg. Med. Chem. Lett., 1998, 8, 511-514.
127. Porter, E.A.; Wang, X.; Lee, H.S.; Weisblum, B.; Gellman, S.H. Non-haemolytic beta-amino-acid oligomers. Nature, 2000, 404 (6778), 565.
128. Porter, E.A.; Weisblum, B.; Gellman, S.H. Mimicry of hostdefense peptides by unnatural oligomers: antimicrobial betapeptides. J. Am. Chem. Soc., 2002, 124, 7324-7330.
129. Raguse, T.L.; Porter, E.A.; Weisblum, B.; Gellman, S.H. Structureactivity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J. Am. Chem. Soc., 2002, 124, 12774-12785.
130. Epand, R.M.; Epand, R.F. Lipid domains in bacterial membranes and the action of antimicrobial agents. BBA-Biomembranes, 2009, 1788 (1), 289-294.
131. Arvidsson, P.I.; Ryder, N.S.; Weiss, H.M.; Gross, G.; Kretz, O., Woessner, R.; Seebach, D. Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. ChemBioChem., 2003, 4, 1345-1347.
132. Patch, J.A.; Barron, A.E. Helical peptoid mimics of magainin-2 amide. J. Am. Chem. Soc., 2003, 125, 12092-12093.
133. Gabriel, J.G.; Som, A.; Madkour, E.A.; Eren, T.; Tew, N.T. Infectious disease: Connecting innate immunity to biocidal polymers. Mater. Sci. Eng., 2007, 57, 28-64.
134. Cheng, R.P.; Gellman, S.H.; DeGrado, W.F. beta-Peptides: from structure to function. Chem. Rev., 2001, 101, 3219-3232.
135. Arvidsson, P.I,; Ryder, Neil.S,; Weiss, H.M,; Gross, G,; Kretz, O,; Woessner, R,; Seebach, D. Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. ChemBioChem, 2003, 4 (12), 1345-1347.
136. Appella, D.H.; Christianson, L.A.; Klein, D.A.; Powell, D.R.; Huang, X.; Joseph, J.; Barchi, J.; Gellman, S.H. Residue-based control of helix shape in β-peptide oligomers. Nature, 1997, 387, 381-384.
137. DeGrado, W.F,; Schneider, J.P,; Hamuro, Y . The twists and turns of beta-peptides. J. Pept. Res., 1999, 54 (3), 206-217.
138. Liu, D.; DeGrado, W.F. De novo design, synthesis, and characterization of antimicrobial beta-peptides. J. Am. Chem. Soc., 2001, 123, 7553-7559.
139. Tew, G.N.; Clements, D.; Tang, H.; Arnt, L.; Scott, R.W. Antimicrobial activity of an abiotic host defense peptide mimic. Biochim. Biophys. Acta Biomembr., 2006, 1758, 1387-1392.
140. Seebach, D.; Matthews, J. L. β-Peptides: a surprise at every turn. Chem. Commun., 1997, 1, 2015-2022.
141. LePlae, P.R.; Fisk, J.D.; Porter, E.A.; Weisblum, B.; Gellman, S.H. Tolerance of acyclic residues in the beta-peptide 12-helix: access to diverse side-chain arrays for biological applications. J. Am. Chem. Soc., 2002, 124, 6820-6821.
142. Wu, C.W.; Seurynck, S.L.; Lee, K.Y.C.; Barron, A.E. Helical Peptoid Mimics of Lung Surfactant Protein C. J. Chembiol., 2003, 10, 1057-1063.
143. Miller, S.M.; Simon, R.J.; Ng, S.; Zuckermann, R.N.; Kerr, J.M.; Moos, W.H. Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide andpeptoid oligomers. Drug Dev. Res., 1995, 35, 20-32.
144. Gibbons, J.A.; Hancock, A.A.; Vitt, C.R.; Knepper; S.; Buckner, S.A.; Brune, M.E.; Milicic, I.; Kerwin, J.F.; Richter, L.S.; Taylor, E.W., Spear, K.L.; Zuckermann, R.N.; Spellmeyer, D.C.; Braeckman, R.A.; Moos, W.H. Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors. J. Pharmacol. Exp. Ther., 1996, 277, 885-899.
145. Wu, C.W.; Sanborn, T.J.; Zuckermann, R.N.; Barron, A.E. Peptoid oligomers with alpha-chiral, aromatic side chains: effects of chain length on secondary structure. J. Am. Chem. Soc., 2001, 123, 2958-2963.
146. Kirshenbaum, K.; Barron, A.E.; Armand, P.; Goldsmith, R.; Bradley, E.; Cohen, F.E.; Dill, K.A.; Zuckermann, R.N. Sequencespecific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc. Natl. Acad. Sci., 1998, 95, 4303-4308.
147. Shuey, S.W.; Delaney, W.J.; Shah, M.C.; Scialdone, M.A. Antimicrobial β-peptoids by a block synthesis approach. Bioorg. Med. Chem. Lett., 2006, 16 (5), 1245-1248.
148. Barron, A.E.; Zuckermann, R.N. Bioinspired polymeric materials: in-between proteins and plastics. Curr. Opin. Chem. Biol., 1999, 3, 681-687.
149. Wender, P.A.; Mitchell, D.J.; Pattabiraman, K.; Pelkey, E.T.; Steinman, L.; Rothbard, J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci., 2000, 97, 13003-13008.
150. Zuckermann, R.N.; Kerr, J.M.; Kent, S.B.H.; Moos, W.H. Efficient Method for the Preparation of Peptoids [Oligo(N-substituted glycines)] by Submonomer Solid-Phase Synthesis.J. Am. Chem. Soc., 1992, 114, 10646-10647.
151. Statz, A.R.; Meagher, R.J.; Barron, A.E.; Messersmith, P.B. New peptidomimetic polymers for antifouling surfaces. J. Am. Chem. Soc., 2005, 127, 7972-7973.
152. Blondelle, S.E.; Lohner, K. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Bio. Polymers, 2000, 55, 74-87.
153. Semetey, V.; Rognan, D.; Hemmerlin, C.; Graff, R., Briand; J.P.; Marraud, M.; Guichard, G. Stable helical secondary structure in short chain N,N'-linked oligoreas bearing proteinogenic side chain. Angew. Chem. Int. Ed. Engl., 2002, 41, 1893-1895.
154. Hemmerlin, C.; Marraud, M.; Rognan, D.; Graff, R.; Semetey, V.; Briand; J.P.; Guichard, G. Helix forming oligoureas: temperaturedependent NMR, structure determination and circular dichroism of a nonomer with functionalised side chain. Helv. Chim. Acta, 2002, 85, 3692-3711.
155. Violette, A.; Averlant-Petit, M.C.; Semetey, V.; Hemmerlin, C.; Casimir, R.; Graff, R.; Marraud, M.; Briand, J.P.; Rognan, D.; Guichard, G. N,N'-linked oligoureas as foldamers: chain length requirements for helix formation in protic solvent investigated by circular dichroism, NMR spectroscopy, and molecular dynamics. J. Am. Chem. Soc., 2005, 127, 2156-2164.
156. 3-residues with side-chain branching adjacent to the β-carbon atom. Helv. Chim. Acta, 2002, 85, 4154-4164.
157. Scheetz, T.; Bartlett, J.A.; Walters, J.D.; Schutte, B.C.; Casavant, T. L.; McCray, P. B. Genomics-based approaches to gene discovery in innate immunity. Immunol. Rev., 2002, 190, 137-145.
158. Digilio, G; Bracco, C; Barbero, L; Chicco, D; Del Curto, MD; Esposito, P; Traversa, S; Aime, S. NMR conformational analysis of antide, a potent antagonist of the gonadotropin releasing hormone. J. Am. Chem. Soc., 2002, 124, 3431-3442.
159. Patel, S.; Stott, I.P.; Bhakoo, M.; Elliott, P. Patenting computerdesigned peptides. J. Comp. Aided. Mol. Des., 1998, 12: 543-556.
160. Lopez, S.F.; Kim, H.S.; Choi, E.C.; Delgado, M.; Granja, J.R.; Khasanov, A.; Kraehenbuehl, K.; Long, G.; Weinberger, D.A.; Wilcoxen, K.M.; Ghadiri, M.R. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature, 2001, 412, 452-455.
161. Soltani, S.; Keymanesh K.; Sardari, S. Evaluation of structural features of membrane acting antifungal peptides by artificial neural networks. J. Biol. Sci., 2008, 8, 834-845.
162. Sardari, S.; Dezfulian, M. Cheminformatics in Anti-infective Agents Discovery. Mini Rev. Med. Chem., 2007, 7, 181-189.
163. Hilpert, K.; Elliott, R. M.; Volkmer, R.; Henklein, P.; Donini, O.; Zhou, Q.; Winkler, F.H.D.; Hancock, W.R.E. Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem. Biol., 2006, 13, 1101-1107.
164. Jenssen, H.; Fjell, C.D.; Cherkasov, A.; Hancock, R.E. QSAR modeling and computer-aided design of antimicrobial peptides. J. Pept. Sci., 2007, 10, 1784-7019.
165. Fernandez, M.; Caballero, J. Analysis of protegrin structurefunction- activity relationships: the structural characteristics important for antimicrobial activity using smoothed amino acid sequence descriptors. Mol. Simul., 2007, 33, 689-702.
166. Goede, A.; Michalsky, E.; Schmidt, U.; Preissner, R. SuperMimic - Fitting peptide mimetics into protein structures. BMC Bioinformatics, 2006, 7, 11.
167. Fullbeck, M.; Michalsky, E.; Jaeger, I. S.; Henklein; P.; Kuhn, H.; Ruck-Braun, K.; Preissner, R. Design and biological evaluation of photo-switchable inhibitors. Genome Informatics, 2006, 17, 141-151.
168. Jones, R. M.; Boatman, D.; Semple, G.; Shin, Y. J.; Tamura, S. Y. Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors. Cur. Opin. Pharmacol., 2003, 3, 530-543.
169. Kritzer, J.A.; Tirado-Rives, J.; Hart, S.A.; Lear, J.D.; Jorgensen, W.L.; Schepartz, A. Relationship between side chain structure and 14-helix stability of beta-peptides in water. J. Am. Chem. Soc., 2005, 127, 167-178.
170. Koerber, S.C.; Rizo, J.; Struthers, R.S.; Rivier, J.E. C. Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling. J. Med. Chem., 2000, 43, 819-828.
171. Digilio, G.; Bracco, C.; Barbero, L.; Chicco, D.; Del Curto, M. D. ; Esposito, P.; Traversa. S.; Aime, S. NMR conformational analysis of antide, a potent antagonist of the gonadotropin releasing hormone. J. Am. Chem. Soc., 2002, 124, 3431-3442.
172. Cho, N.; Harada, M.; Imaeda, T.; Imada, T.; Matsumoto, H.; Hayase, Y.; Sasaki, S.; Furuya, S.; Suzuki, N.; Okubo, S. Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor. J. Med. Chem., 1998, 41, 4190-4195.
173. Neil, J.M.; Andruszkiewicz, R.; Gupta, S.; Milewski, S.; Payne, J.W. Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues. J. Antimicrob. Chemother., 2003, 51, 821-831.
174. Sugg, E.E. Annu. Nonpeptide agonists for peptide receptors: lessons from ligands. Rep. Med. Chem., 1997, 32, 277-283.
175. Bianchini, G.; Aschi, M.; Cavicchio, G.; Crucianelli, M.; Preziuso, S.; Gallina, G.; Nastari, A.; Gavuzzod, E.; Mazzaa, F. Design, modelling, synthesis and biological evaluation of peptidomimetic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8. Bioorg. Med. Chem., 2005, 13, 4740-4749.
176. Araya, E.; Rodriguez, A.; Rubio, J.; Spada, A.; Joglar, J.; Llebaria, A.; Lagunas, C.; Fernandez, A.G.; Spisanie, S.; Perez, J.J. Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T. Bioorg. Med. Chem. Lett., 2005, 15, 1493-1496.
177. Gonzalez, M.P.; Caballero, J.; Tundidor-Camba, A.; Helguerab, A.M.; Fernandezc, M. Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches. Bioorg. Med. Chem., 2006, 14, 200-213.
178. Zhang, J.; Liu, L.; Guo, Y.; Yang, J.; Wei, L.; Zhong, D.; Wang, J. Design and Synthesis of a Novel Peptidomimetic Inhibitor of Caspase-3. Chem. Res. Chin. Univ., 2006, 22, 225-228.
179. Nantermet, P.G.; Burgey, C.S.; Robinson, K.A.; Pellicore, J.M.; Newton, C.N.; Deng, J.Z.; Selnick, H.G.; Lewis, S.D.; Lucas, B.J.; Krueger, J.A. P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffold. Bioorg. Med. Chem. Lett., 2005, 15, 2771-2775.
180. Smith, A.B.; Cho, Y.S.; Pettitb, G.R.; Hirschmanna, R. Design, synthesis, and evaluation of azepine-based cryptophycin mimetics. Tetrahedron, 2003, 59, 6991-7009.
181. Larsen, S.D.; Stevens, F.G.; Lindberg, T.J.; Bodnar, P.M., O'Sullivan, T.J.; Schostarez, H.J.; Palazuk, B.J.; Bleasdaleb, J.E. Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity. Bioorg. Med. Chem. Lett., 2003, 13, 971-975.
182. Turkson, J.; Kim, J.S.; Zhang, S.; Yuan, J.; Huang, M.; Glenn, M.; Haura, E.; Sebti, S,; Hamilton, A.D.; Jove, R. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther., 2004, 3 (3), p.261-269.
183. Heerding, D.A.; Abruzzese, M.; Alberts, D.; Burgess, J.; Callahan, J.F.; Huffman, W.F. Novel peptidomimetic hematoregulatory compounds. Bioorg. Med. Chem. Lett., 2000,10, 531-534.
184. Hippenmeyer, P.J.; Ruminski, P.G.; Rico, J.G.; Lu, H.S.; Griggs, D.W. Adenovirus inhibition by peptidomimetic integrin antagonists. Antivir. Res., 2002, 55, 169-178.
185. Zhong, H.; Carlson, H.A. Computational studies and peptidomimetic design for the human p53-MDM2 complex. Proteins, 2005, 58, 222-234.
186. Kadono, S.; Sakamoto, A.; Kikuchi, Y.; Oheda, M.; Yabuta, N.; Yoshihashi, K.; Kitazawa, T. Structure-based design of P3 moieties in the peptide mimetic factor VIIa inhibitor. Biochem. Biophy. Res. Comm., 2005, 327, 589-596.
187. Soltani, S.; Keymanesh, K.; Sardari, S. In Silico analysis of antifungal peptides (AFPs): Determining the lead template sequence of potent antifungal peptides. Expert Opin. Drug. Discov., 2007, 2, 837-847.
188. Marshall, N.J.; Andruszkiewicz, R.; Gupta, S.; Milewski, S.; Payne, J.W. Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues. J. Antimicrob. Chemother., 2003, 51, 821-831.
189. Goodman, M; Shao, H. Peptidomimetic building blocks for drug discovery: an overview. Pure. Appl. Chem., 1996, 68, 1303-1308.